申请人:Rigel Pharmaceuticals, Inc.
公开号:US20140213585A1
公开(公告)日:2014-07-31
This invention is directed to methods of treating diseases or conditions associated with JAK2 activity in a mammal comprising the administration of a compound of formula (I):
where
n, m, Y, R
1
, R
2
, R
3
, R
4
and R
5
are disclosed herein, or a pharmaceutically acceptable salt.
本发明涉及用于治疗哺乳动物中与JAK2活性相关疾病或病症的方法,包括给予以下公式(I)的化合物或其药学上可接受的盐:其中n,m,Y,R1,R2,R3,R4和R5在此被披露。